<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The neuroprotective potential of <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi>:water (1:1) extract of rhizomes of Acorus calamus (AC-002) has been investigated in middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO)-induced <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>A significant behavioural impairment in Rota-Rod performance and grid walking was observed in rats, 72 hours after MCAO as compared to sham-operated animals </plain></SENT>
<SENT sid="2" pm="."><plain>These rats also exhibited an increase in <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation (cortex -157%, corpus striatum - 58%) and a decrease in <z:chebi fb="0" ids="16856">glutathione</z:chebi> levels (cortex - 59%, corpus striatum - 34%) and <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD) activity (cortex - 64%, corpus striatum - 32%) as compared to sham-operated animals </plain></SENT>
<SENT sid="3" pm="."><plain>Ischaemic rats treated with AC-002 (25 mg/kg, p.o.) exhibited a significant improvement in neurobehavioural performance viz </plain></SENT>
<SENT sid="4" pm="."><plain>Rota-Rod performance and grid walking as compared to the MCAO group </plain></SENT>
<SENT sid="5" pm="."><plain>Interestingly, treatment with AC-002 in MCAO rats significantly decreased malonaldialdehyde levels in cortex as compared to ischaemic rats </plain></SENT>
<SENT sid="6" pm="."><plain>A significant increase in reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> levels and SOD activity was also observed both in cortex and corpus striatum in MCAO rats treated with AC-002 in comparison to MCAO rats </plain></SENT>
<SENT sid="7" pm="."><plain>Treatment with AC-002 in MCAO rats also reduced the contralateral cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> area (19%) as compared to MCAO rats (33%) </plain></SENT>
<SENT sid="8" pm="."><plain>Neurological function score was improved in the AC-002-treated rats as compared to the MCAO group </plain></SENT>
<SENT sid="9" pm="."><plain>The results of the present study indicate the neuroprotective efficacy of A. calamus in the rat model of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
</text></document>